Literature DB >> 26271109

Blood Pressure Levels at the Time of Percutaneous Coronary Revascularization and Risk of Coronary In-Stent Restenosis.

Giuliano Tocci1, Emanuele Barbato2, Roberta Coluccia3, Anna Modestino3, Beniamino Pagliaro3, Vittoria Mastromarino3, Francesca Giovannelli3, Andrea Berni3, Massimo Volpe4.   

Abstract

BACKGROUND: High blood pressure (BP) levels expose patients treated with percutaneous coronary interventions (PCI) to very high risk of 10-year cardiovascular morbidity and mortality.
OBJECTIVE: To investigate the role of BP levels at the time of PCI on the risk of in-stent restenosis (ISR).
METHODS: We retrospectively included 796 patients previously treated with PCI, who underwent repeated angiography for recurrent angina or reversible myocardial ischemia. Patients were stratified into either case (n = 354) and control (n = 442) groups in the presence or absence of ISR (defined as in-stent diameter stenosis ≥50%). BP levels were measured at the time of first and second procedures. Normal BP levels were defined for <140/90 mm Hg.
RESULTS: Patients with normal BP showed significantly higher ISR-free survival (Log-rank: 5.937; P = 0.015). Both systolic (HR (95% CI): 0.731 (0.590-0.906)) and systolic/diastolic BP (HR (95% CI): 0.757 (0.611-0.939)) were significantly and independently associated with lower risk of ISR at Cox-regression analysis, adjusted for potential confounding factors, including stent type and concomitant medications. Patients with ISR showed lower rates of normal systolic/diastolic BP values (166 (47%) vs. 254 (57%); P = 0.003) compared to controls. They also received higher stent number (1.40±0.74 vs. 1.24±0.51; P < 0.001) with higher stent length (24.3±15.6 vs. 21.7±13.9 mm; P = 0.012), and lower rate of drug-eluting stents (DESs) (210 (48%) vs. 139 (40%); P = 0.025) compared to controls.
CONCLUSIONS: Normal BP at the time of PCI is associated with nearly 24% risk reduction of ISR as evaluated in a new angiography in patients with coronary artery disease. © American Journal of Hypertension, Ltd 2015. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  coronary artery disease; high blood pressure; hypertension; in-stent restenosis; percutaneous revascularization.

Mesh:

Year:  2015        PMID: 26271109      PMCID: PMC4886488          DOI: 10.1093/ajh/hpv131

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  37 in total

Review 1.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

2.  Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score.

Authors:  Catherine McGorrian; Salim Yusuf; Shofiqul Islam; Hyejung Jung; Sumathy Rangarajan; Alvaro Avezum; Dorairaj Prabhakaran; Wael Almahmeed; Zvonko Rumboldt; Andrzej Budaj; Antonio L Dans; Hertzel C Gerstein; Koon Teo; Sonia S Anand
Journal:  Eur Heart J       Date:  2010-12-22       Impact factor: 29.983

3.  European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Ian Graham; Dan Atar; Knut Borch-Johnsen; Gudrun Boysen; Gunilla Burell; Renata Cifkova; Jean Dallongeville; Guy De Backer; Shah Ebrahim; Bjørn Gjelsvik; Christoph Herrmann-Lingen; Arno Hoes; Steve Humphries; Mike Knapton; Joep Perk; Silvia G Priori; Kalevi Pyorala; Zeljko Reiner; Luis Ruilope; Susana Sans-Menendez; Wilma Scholte Op Reimer; Peter Weissberg; David Wood; John Yarnell; Jose Luis Zamorano; Edmond Walma; Tony Fitzgerald; Marie Therese Cooney; Alexandra Dudina; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Christian Funck-Brentano; Gerasimos Filippatos; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; Jóse Luis Zamorano; Attila Altiner; Enzo Bonora; Paul N Durrington; Robert Fagard; Simona Giampaoli; Harry Hemingway; Jan Hakansson; Sverre Erik Kjeldsen; mogens Lytken Larsen; Giuseppe Mancia; Athanasios J Manolis; Kristina Orth-Gomer; Terje Pedersen; Mike Rayner; Lars Ryden; Mario Sammut; Neil Schneiderman; Anton F Stalenhoef; Lale Tokgözoglu; Olov Wiklund; Antonis Zampelas
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-09

Review 4.  Pathophysiology of coronary artery restenosis.

Authors:  Robert S Schwartz; Timothy D Henry
Journal:  Rev Cardiovasc Med       Date:  2002       Impact factor: 2.930

5.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

6.  Admission blood pressure and 1-year mortality in acute myocardial infarction.

Authors:  D Roth; R Van Tulder; B Heidinger; H Herkner; W Schreiber; C Havel
Journal:  Int J Clin Pract       Date:  2015-02-06       Impact factor: 2.503

7.  Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty.

Authors:  H Tashiro; H Shimokawa; K Sadamatsu; T Aoki; K Yamamoto
Journal:  Coron Artery Dis       Date:  2001-03       Impact factor: 1.439

8.  Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA study.

Authors:  Claudio Cimminiello; Claudio Borghi; Serge Kownator; Jean Claude Wautrecht; Christos P Carvounis; Stefanus E Kranendonk; Beat Kindler; Mario Mangrella
Journal:  BMC Cardiovasc Disord       Date:  2010-08-05       Impact factor: 2.298

Review 9.  Growth factors in pathogenesis of coronary arterial restenosis.

Authors:  B Cercek; B Sharifi; P Barath; L Bailey; J S Forrester
Journal:  Am J Cardiol       Date:  1991-11-04       Impact factor: 2.778

10.  Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

Authors:  S Yusuf; K Teo; C Anderson; J Pogue; L Dyal; I Copland; H Schumacher; G Dagenais; P Sleight
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

View more
  6 in total

1.  In-Stent Restenosis: Pathophysiology and Treatment.

Authors:  Patrick M Looser; Luke K Kim; Dmitriy N Feldman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

2.  In-Hospital Outcomes of Coronary Artery Stenting in Patients With ST-Elevation Myocardial Infarction (STEMI) and Metabolic Syndrome: Insights From the National Inpatient Sample.

Authors:  Owen Igbinosa; Ahmed Brgdar; Joseph Asemota; Mohamed E Taha; Jin Yi; Anthony Lyonga Ngonge; Swati Vanaparthy; Raccquel Hammonds; Joseph Talbet; Diannemarie Omire-Mayor; Julius Ngwa; Muhammad Rizwan; Mehrotra Prafulla; Isaac Opoku
Journal:  Cureus       Date:  2022-05-02

3.  Visit-to-visit variability of systolic blood pressure predicts all-cause mortality in patients received percutaneous coronary intervention with drug-eluting stents.

Authors:  Suk Min Seo; Woo-Baek Chung; Ik Jun Choi; Yoon-Seok Koh; Sang-Hyun Ihm; Pum-Jun Kim; Wook Sung Chung; Ki-Bae Seung
Journal:  Heart Vessels       Date:  2017-11-18       Impact factor: 2.037

4.  Effect of multiple clinical factors on recurrent angina after percutaneous coronary intervention: A retrospective study from 398 ST-segment elevation myocardial infarction patients.

Authors:  Jing Zhang; Chengyu Liu; Chenliang Pan; Ming Bai; Jin Zhang; Yu Peng; Dingchang Zheng; Zheng Zhang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

5.  The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention.

Authors:  Long Tang; Qian-Wei Cui; Dan-Ping Liu; Ying-Ying Fu
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

6.  Determinant of repeat revascularization within 5 years of Percutaneous Coronary Intervention at a tertiary care hospital, Karachi: A matched case-control study.

Authors:  Komal Valliani; Azmina Artani; Iqbal Azam; Javed Tai; M Masood Kadir
Journal:  Ann Med Surg (Lond)       Date:  2022-02-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.